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Abstract
A mathematical model of interstitial fluid flow is developed, based on the application of the governing equations for fluid
flow, i.e., the conservation laws for mass and momentum, to physiological systems containing solid tumors. The discretized
form of the governing equations, with appropriate boundary conditions, is developed for a predefined tumor geometry.
The interstitial fluid pressure and velocity are calculated using a numerical method, element based finite volume.
Simulations of interstitial fluid transport in a homogeneous solid tumor demonstrate that, in a uniformly perfused tumor,
i.e., one with no necrotic region, because of the interstitial pressure distribution, the distribution of drug particles is non-
uniform. Pressure distribution for different values of necrotic radii is examined and two new parameters, the critical tumor
radius and critical necrotic radius, are defined. Simulation results show that: 1) tumor radii have a critical size. Below this size,
the maximum interstitial fluid pressure is less than what is generally considered to be effective pressure (a parameter
determined by vascular pressure, plasma osmotic pressure, and interstitial osmotic pressure). Above this size, the maximum
interstitial fluid pressure is equal to effective pressure. As a consequence, drugs transport to the center of smaller tumors is
much easier than transport to the center of a tumor whose radius is greater than the critical tumor radius; 2) there is a
critical necrotic radius, below which the interstitial fluid pressure at the tumor center is at its maximum value. If the tumor
radius is greater than the critical tumor radius, this maximum pressure is equal to effective pressure. Above this critical
necrotic radius, the interstitial fluid pressure at the tumor center is below effective pressure. In specific ranges of these
critical sizes, drug amount and therefore therapeutic effects are higher because the opposing force, interstitial fluid
pressure, is low in these ranges.
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Introduction
Cancer is the second leading cause of death, causing one of
every four deaths in North America [1]. Although the most
important treatment is surgical removal of the tumor, the key to a
successful cure is often an efficient delivery of anticancer drugs
after the surgery. Many new drugs have been developed to
eradicate cancer but are ineffective when used in humans for lack
of efficient delivery. Moreover, all drugs have possible side effects,
such as toxicity to normal cells and the development of drug
resistance [2]. Residual tumor cells and re-growth of tumors are
common sequels to the use of most of these drugs. The drugs’ most
noticeable limitation is their inability to reach a targeted area
without affecting healthy tissues or cells. The two considerations in
effective cancer treatment, from an engineering point of view, are
drug transport and drug conversion or reaction at the tumor site
[3,4]. Many drugs cannot be delivered to their targets because of
transport limitations. Other drugs induce biochemical reactions in
the body that produce toxicity.
It is known that more than 85% of human cancers involve solid
tumors, and current chemotherapy depends on the adequate
delivery of therapeutic agents to tumor sites [1]. It is also well
recognized that the blood supply to a solid tumor is highly
heterogeneous [5,6]. In fact, drug concentration is highest closest
to vasculature, well-perfused areas, and on the peripheral walls of
the tumor, but very little or no drug reaches 90% of the tumor
[7,8]. However, for successful cancer treatment, all areas of the
tumor must be exposed to chemotherapy agents. If just the tumor’s
outer cells are killed, the tumor will eventually regrow [9].
According to clinical research findings, even though drug
delivery through systemic administration may inhibit tumor
growth, most drug treatments fail to eliminate malignant tumors
completely [10]. Some experimental and computational investi-
gations show that systemic administration cannot distribute drugs
uniformly in tumors. Baxter et al. have shown that, in addition to
blood flow heterogeneities and impeded interstitial transport,
another mechanism effectively contributes to the non-uniform
distribution of drugs: high interstitial pressure in solid tumors [11–
13]. There are two important effects of this high interstitial
pressure, and these effects limit transport in solid tumors. These
two effects are illustrated schematically in Fig. 1. The first effect is
a decrease in driving force for transcapillary exchange of fluid and
therefore the drug. This effect is highlighted in Fig. 1. Low
filtration occurs at the center of the tumor as a result of the high
interstitial pressure and high filtration occurs at the periphery of
the tumor as a result of the low interstitial pressure. The second
effect is a radially outward convective flux in the interstitium as
fluid flows towards the outer layers of the tumor. This effect is
illustrated in Fig. 1 as an outward convection due to pressure
gradient. The value of the radially outward fluid velocity at the
tumor rim for a tumor with a 1 cm radius, 4.2 g , is 0:1*0:2mm=s
[3]. Another important process in drug delivery is indicated in this
schematic, Fig. 1, as an inward diffusion due to concentration
gradient of the drug. Effective penetration into a solid tumor
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e20344requires that the velocity of the diffusion process be higher than
that of the convection process [14]. On the other hand, uniformly
distributed high interstitial pressure in the center of a tumor blocks
convection and, consequently, causes the heterogeneous perfusion
of blood into the center of tumors, resulting in the heterogeneous
distribution of the drug [13]. The existence of pressure gradients in
tumors discovered by Baxter et al. is confirmed by Boucher et al.
[15]. Baxter and Jain, using their theoretical framework, further
Figure 1. Cross sectional schematic of a solid tumor that shows the three different regions of a solid tumor, IFP distribution, drug
concentration and filtration distribution from blood vessels.
doi:10.1371/journal.pone.0020344.g001
Figure 2. Capillary microcirculation schematic and different types of pressure.
doi:10.1371/journal.pone.0020344.g002
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fluids, vascular permeability and lymphatic drainage are important
factors in determining the drug concentration in tumors [3,16,17].
Netti et al. showed that interstitial fluid pressure (IFP) depends on
microvascular pressure and blood flow within tumors [18].
Extending the one-dimensional models of Baxter and Jain
[3,16,17], and Saltzman and Radomsky [19], to a three-
dimensional geometry, Wang et al. [20–25] developed a
simulation framework of drug delivery to tumors. They considered
high interstitial pressure in tumors [13], the consequences of blood
and lymphatic drainage, and the chemical reaction of the drug
with the tissue. The main focus of their work was on using
diffusion-convection kinetics to improve simulation result accura-
cy. They showed that in vitro release profile of the drug from
controlled release devices can be combined with state of the art
computational fluid dynamics (CFD) simulations to predict the
drug delivery behavior, both temporally and spatially, in both
normal and cancerous tissues. The focus of their work was the
mathematical modeling of the drug release from polymer implants
that have certain characteristics of release profile. By applying
sensitivity analysis, Zhao et al. [26] determined the effect of
spatially changing tissue transport properties on interstitial fluid
(including drug particles) transport.
Knowledge of tumor modeling has recently been expanded to
include spatial and temporal changes in blood flow by considering
capillary network or single vessel approaches [27,28]. Before
Baxter et al. [3,16,17] introduced their innovative model of
interstitial pressure as a function of tumor radius, little was known
about tumor modeling, except that interstitial pressure was highest
at the center of a tumor [29] and that pressure is directly
proportional to tumor size [29,30]. The promising combined
therapies such as radiotherapy and antiangiogenic therapy in
addition to chemotherapy in tumor treatment are good examples
that can show the crucial role of the modeling. For example, the
computational fluid dynamics modeling results can be applied to
optimize the interaction effect of the irradiation to the drug
delivery efficiency. The main focus of future drug delivery
modeling would be on the transport of the drug in tissues after
drug release from either the systemic administration or implan-
tation mechanisms. Modeling in drug delivery involves different
processes such as drug diffusion, convective transport in
extracellular matrices, drug extravasation from blood vessels,
Figure 3. Two types of boundary conditions at the outer edge of the tissue.
doi:10.1371/journal.pone.0020344.g003
Table 1. Material properties used in numerical simulations, as
taken from [13].
Parameter Tissue Baseline value Reference
Lp½cm=mmHg s  Normal 0:36|10{7 Rippe et al. (1978)
Tumor 2:80|10{7 Jain (1987a)
k½cm2=mmHg s  Normal 8:53|10{9 Swabb et al. (1974)
Tumor 4:13|10{8 Jain (1987a)
S=V½cm{1  Normal 70 Pappenheimer et al.
(1951)
Tumor 200 Hilmas and Gilette
(1974)
PB½mmHg  Both 15:6 Brace and Guyton
(1977)
pB½mmHg  Both 20 Brace and Guyton
(1977)
pi½mmHg  Normal 10 Wiederhielm (1979)
Tumor 15 Jain (1987a)
ss½mmHg  Normal 0:91 Ballard and perl (1978)
Tumor 0:82 Curry (1984)
doi:10.1371/journal.pone.0020344.t001
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ization. In all of these processes, CFD can play a crucial role. To
clarify the mechanisms of drug delivery from the injection site to
absorption by a solid tumor, computational fluid dynamics has
shown promise. So far, drug delivery problems have been most
extensively studied with spherical tumors, the simplest to examine
with analytical methods. With our proposed numerical method,
however, more complex shapes of tumor can be studied.
Numerical simulations provide a detailed understanding of the
mechanisms of interstitial fluid transport and are also instructive to
show some of the major barriers to drug delivery to solid tumors.
With this knowledge, one can find, for example, an optimum
schedule of drug treatment based on the simulation results. To
design an optimum scheme for drug delivery, the transport
mechanisms and their obstacles have to be clarified, which is one
of the main objectives of this paper.
The proposed CFD model is made for a spherical tumor and its
surrounding normal tissue. However, this model can be extended
to study non-spherical tumors, especially those geometries
reconstructed from high resolution images. The grid generation
divides the whole domain or geometry to finite volumes, called
meshes. Tetrahedral elements can be used to handle non-spherical
tumors. The tumor and its surrounding tissue are assumed to be
rigid porous media. The vasculature as a source term varies
spatially. Interstitial fluid flow equations in porous media are
solved using a CFD code which employs unstructured grids. In
studying interstitial fluid pressure distribution, the numerical
method, which introduces two critical parameters (tumor radius
and necrotic radius), is more effective than the analytical method.
Methods
Drug Transport within Solid Tumor
Fluid seeps slowly but constantly from blood vessels into
surrounding tissues in most normal tissues. The lymphatic system
then reabsorbs this lost fluid and returns it to the blood stream.
However, no such lymphatic drainage system for solid tumors has
been reported in the literature [3,4]. Computer simulations show
that this lack of lymphatic system involvement may result in a
buildup of interstitial pressure, leading to cessation of the usual
blood seepage from vessels. As a consequence, large molecules
(including cancer-fighting drugs) cannot be carried out of vessels to
interact with tissue. Thus, cancer drugs cannot reach the tumor site.
Some drug particles, such as Monoclonal Antibodies (MAbs),
are relatively large and move very slowly within tissues [3]. To be
effective, these large anticancer agents have to cross the blood
vessel wall, traverse the interstitial space that contains the cancer
cells, bind to the cancer cell membranes and, if the target is
intracellular, penetrate the cancer cell membranes.
Tissue spaces are made up of three parts, all of which are
relevant to the delivery of drugs to tumors: the vascular, the
interstitial, and the cellular. The vascular space comprises the
blood vessels, arteries, arterioles, capillaries, venules, and veins
[31]. The interstitial space, a gel-like region between blood vessels
and cells, is filled with fibers such as collagen, which gives
structural stability, glycosaminoglycans (GAG), and other proteins.
The cellular space includes specific tissue cells (cancer cells in a
solid tumor), in addition to other cells, such as pericytes,
macrophages, and fibroblasts [3,16,17].
Figure 4. Interstitial velocity distribution in a 1 cm radius tumor, different values of a, Eq. (16).
doi:10.1371/journal.pone.0020344.g004
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doi:10.1371/journal.pone.0020344.g005
Figure 6. Interstitial pressure distribution in the same tumor (a~36:8).
doi:10.1371/journal.pone.0020344.g006
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The distribution of vasculature and cells in solid tumors is
spatially heterogeneous. In the center of solid tumors, there is a
necrotic core where most of the cells are dead. The outer
boundary of solid tumors contains many exchange vessels, a
large blood supply, and fast-dividing cells. Therefore, the
mathematical model should be accurate enough to include the
dependency of physiological parameters, such as the hydraulic
conductivity, on space, that is, it must be able to clearly
represent all the physical variations in a tumor. Nevertheless,
because the time scale of transport phenomena is much less than
that of tumor growth, the physiological parameters can be
considered time independent [3]. For the sake of simplicity, solid
tumors are considered here to be spherical. In a macroscopic
model, only the distribution of variables, such as interstitial
pressure and concentration, over the length scale of the tumor
radius is important, and microscopic characteristics, such as
blood vessels, cells, and the interstitial matrix, are not involved
directly in the model. Comparison of the tumor radius, on the
order of magnitude of 1cm, O(1cm), with the intercapillary
distance (the average distance between two capillaries),
O(100mm), indicates that variations over microscopic length
scales can be averaged out [32]. The screening length,
ﬃﬃﬃﬃﬃﬃ
mk
p
(in
which m and k are the viscosity of the interstitial fluid and the
hydraulic conductivity of the interstitium, respectively), is on the
order of A ˚; therefore, the fluid transport in the tumor
interstitium can be described by Darcy’s law for flow through
a porous medium [4,32–36]:
v~{k+Pi in general
v~{k
LPi
Lr
for axisymmetric flow
ð1Þ
where k½cm2=mmHg s , Pi½mmHg , v½m=s  and r½cm  are the
hydraulic conductivity of the interstitium, the interstitial fluid
pressure, the interstitial fluid velocity and the radial position,
respectively. In the case of anisotropic and heterogeneous porous
media, k is a tensor and function of the location in the medium.
TherearesomelimitationstotheuseofDarcy’slaw.Forinstance,itis
not applicable for non-Newtonian fluids, Newtonian fluids at high
velocities, or for gases at very low or very high velocities. It is also
shown that the friction within the fluid and exchange of momentum
between the fluid and solid phases is neglected by Darcy’s law.
Fortunately, in the interstitium of biological tissues, all these
exceptional cases are rare (most of the phenomena are low velocity
for Newtonian fluids)except for the friction withinthe fluid; therefore,
Darcy’s law is quite applicable to the analysis of interstitial fluid flow.
The mass balance equation for a steady state incompressible
fluid is that the divergence of the fluid is zero, or mathematically,
+:v~0 ð2Þ
The same equation is also applicable in porous media if there is
no fluid source or fluid sink in the medium. However, in most
Figure 7. Three dimensional plot of Fig. 6, dimensionless interstitial pressure distribution, in the same tumor (a~36:8).
doi:10.1371/journal.pone.0020344.g007
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doi:10.1371/journal.pone.0020344.g008
Figure 9. Interstitial velocity distribution in a 1.4 cm radius tumor and normal tissue.
doi:10.1371/journal.pone.0020344.g009
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between interstitial space and the blood or lymph vessels, fluid is
exchanged; therefore, the steady state incompressible form of the
continuity equation must be modified as
+:v~wB(r){wL(r) ð3Þ
where v is the fluid velocity in the representative elementary
volume (REV). The continuity equation can also be written as
+:( vf)~
wB(r){wL(r) for r§Rn
0 for rvRn
8
> <
> :
ð4Þ
where Rn½cm ,  , vf½ms{1 , wB(r)½s{1 ,a n dwL(r)½s{1  are the
radius of the necrotic core, the porosity or the volume fraction of
fluid, the fluid velocity averaged in the volume of fluid phase, the
fluid source term, and the lymphatic drainage term, respectively. In
biological tissues, the two last terms signify the rate of fluid flow per
unit volume from blood vessels into the interstitial space and from
the interstitial space into lymph vessels, respectively. Both rates can
be evaluated through Starling’s law. It should be noted that Eq. (4)
in this general form is applicable to any kind of biological tissue,
whether normal or cancerous. In dead tissues, with no flow in the
blood or lymph vessels, the value for both terms is zero. The fluid
source term is governed by Starling’s law as follows [37,38]:
wB(r)~
JV
V
~
LPS
V
(PB{Pi{ss(pB{pi)) ð5Þ
The parameters used in Eq. (5) are:
JV
V
½s{1 , volumetric flow rate
out of the vasculature per unit volume of tissue;
S
V
½cm{1 , surface
area per unit volume for transport in the tumor; Lp½
cm
mmHg s
 ,
hydraulic conductivity of the microvascular wall; PB½mmHg ,
vascular pressure; ss, average osmotic reflection coefficient for
plasma proteins; pB½mmHg , osmotic pressure of the plasma; and
pi½mmHg , osmotic pressure of the interstitial fluid. Different types
of pressure used in Eq. (5) are shown in Fig. 2. It should be noted
that the lymphatic drainage term is proportional to the pressure
difference between the interstitium and the lymphatics:
wL(r)~
JL
V
~
LPLSL
V
(Pi{PL) for r§Rn
wB(r)~wL(r)~0 for rvRn
ð6Þ
The parameters used in these equations are:
JL
V
½s{1 , volumetric
flow rate into the lymphatics; LpL½
cm
mmHg s
 , hydraulic conduc-
tivity of the lymphatic wall; and PL½mmHg , hydrostatic pressure of
the lymphatics.
Figure 10. Interstitial pressure distribution in a 1.4 cm radius tumor and normal tissue.
doi:10.1371/journal.pone.0020344.g010
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{+:k+Pi~wB(r){wL(r) ð7Þ
For a very special case, when k is constant and there are no
sinks and sources, the interstitial pressure can be expressed by the
very well-known Laplace equation.
+2Pi~0 ð8Þ
If all parameters except Pi are assumed to be constant,
substituting Eqs. (5) and (6) in Eq. (7) results in
{k+2Pi~
LPS
V
(PB{Pi{ss(pB{pi)){
LPLSL
V
(Pi{PL) ð9Þ
Rearranging Eq. (9) for a spherical solid tumor with radius R,
+2Pi~
a2
R2 (Pi{Pss) ð10Þ
PSS is defined later by Eq. (14). Using the definition of Laplace
operator, Eq. (11), in the spherical coordinate system, Eq. (10) is
written as Eq. (12).
D~+2~
1
r2
L
Lr
r2 L
Lr
  
z
1
r2 sinh
L
Lh
sinh
L
Lh
  
z
1
r2 sin
2 h
L
2
L
2w
ð11Þ
1
r2
L
Lr
r2 LPi
Lr
  
~
a2
R2 (Pi{Pss) ð12Þ
in Eqs. (10) and (12), the ratio of interstitial resistance to vascular
resistance is introduced in terms of a, the dimensionless parameter
defined by Eq. (13).
a~R
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
(LPSzLPLSL)=kV
p
ð13Þ
PSS~(LPSPezLPLSLPL)=(LPSzLPLSL) ð14Þ
the steady state pressure, PSS, is the interstitial pressure at which
the efflux from the vasculature and influx into the lymphatics are
equal, and is defined by Eq. (14). Effective pressure, Pe, in Eq. (14),
is a parameter defined by vascular pressure, plasma osmotic
pressure, and interstitial osmotic pressure through Eq. (15).
Pe~PB{ss(pB{pi) ð15Þ
Figure 11. Interstitial pressure distribution in a 1 cm radius tumor, as a function of the dimensionless radius for different necrotic
radii.
doi:10.1371/journal.pone.0020344.g011
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constants mentioned earlier, the governing equation, Eq. (10) or
(12), can be used to calculate the interstitial fluid velocity (IFV) and
interstitial fluid pressure (IFP) profiles in solid tumors. No lymph
vessels in a solid tumor means SL~0; thus, Eqs. (12) and (13) can
be simplified as follows:
1
r2
L
Lr
r2 LPi
Lr
  
~
a2
R2 (Pi{Pe) ð16Þ
a~R
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
(LPS)=kV
p
ð17Þ
in which the interstitial pressure that yields zero net volume flux
out of the vasculature is called the effective pressure, Pe, Eq. (15).
The steady state pressure and effective pressure in solid tumors
with no lymph vessels are the same. If Pi~Pe, no exchange of
fluid occurs between the interstitial space and blood vessels.
Due to symmetry, there is a no flux boundary condition at the
center of the tumor; i.e.,
+Pi~0o r
LPi
Lr
~0f o r r~0 ð18Þ
At the outer edge of the solid tumor, r~R, two types of
boundary conditions are possible. In the first type, where the
pressure in the surrounding tissue is fixed, the tumor pressure at
the outer edge is the same as the surrounding pressure, Psur.
Pi~Psur forr~R ð19Þ
This condition is applicable for an isolated tumor [39,40]. In the
second type, the solid tumor is surrounded by normal tissues.
Pressure decreases smoothly over a distance; therefore, the
continuity of pressure and velocity should be considered as an
appropriate boundary condition for this case as the following
conditions occur simultaneously:
{kt
dPi
dr
       
R{
~{kn
dPi
dr
       
Rz
ð20Þ
PijR{~PijRz ð21Þ
where R{ and Rz indicate the tumor and normal tissue radius at
the outer edge of the solid tumor; kt and kn are the hydraulic
conductivity of the interstitium in tumor and normal tissues,
respectively. It should be noted that, in the second type, all the
equations mentioned for the tumor tissue have to be solved for the
normal tissue, as well. It is clear that for the normal tissue, far
enough from the solid tumor that the pressure is constant, the first
type of boundary condition, Eq. (19), must be applied. These two
types of boundary conditions are shown in Fig. 3. The solution
now can be obtained analytically or numerically to find the IFV
and IFP profiles for each of the two boundary conditions. In this
Figure 12. Interstitial pressure distribution at the center of a 1 cm radius tumor, as a function of the dimensionless necrotic radius.
doi:10.1371/journal.pone.0020344.g012
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doi:10.1371/journal.pone.0020344.g013
Figure14.Interstitialpressuredistributionina0.5 cmradiustumor,asafunctionofthedimensionlessradiusfordifferentnecroticradii.
doi:10.1371/journal.pone.0020344.g014
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volume method (EB-FVM) is applied to discretize the equations.
The EB-FVM hasthecapability of the finiteelement method (FEM)
in handling complex geometries and also the sound physical-based
properties of the finite volume method (FVM) [41]. The discretized
form of the governing equations, in their general form, is then
linearized and solved implicitly. The SIMPLE (Semi Implicit
Method for Pressure Linked Equations) algorithm is used as the
coupling method for pressure and velocity terms. Finally, the
converged form of the solution is calculated using an iterative
method. In order to improve the convergence rate, the method of
successiveover-relaxation(SOR)isappliedwith anunderrelaxation
factor equal to 0.75. The criterion for the convergence is to reduce
the residual by 6 orders of magnitudes. In order to check the grid
independency of the code, the results for three different grids are
compared, indicating the conservative property of the numerical
method. Final choice of the grid includes 11904 control volumes.
The material properties for tumor and normal tissue were taken
from the simulation studies of Jain and Baxter [13] and are shown
in Table 1. It should be noted that tissue properties vary greatly
among different organs for both normal and cancerous tissues;
therefore, parameters introduced in Table 1 should be updated for
new applications. As mentioned earlier, tissue transport properties
are often anisotropic. Geometric and physiological properties of
anisotropic and heterogeneous tissues affect drug delivery. This
issue can be solved with the help of diffusion tensor imaging (DTI).
A good application of this method in brain tumors is discussed by
Linninger et al. [42].
Results
Figure 4 shows the unidirectional interstitial fluid velocity
distribution in an isolated solid tumor as a function of the
dimensionless radius. This figure shows that the higher the value of
a is, the steeper the velocity profiles will be. Figure 5 shows the
unidirectional interstitial fluid pressure distribution in an isolated
solid tumor as a function of the dimensionless radius. Low values
of a corresponding to flat curves show less resistance to fluid
source, but high values of a corresponding to sharp curves in the
periphery of the tumor show greater resistance to fluid source,
based on the definition of dimensionless parameter a. Figure 6
shows IFP distribution based on the parameters’ values introduced
in Table 1 which results in a~36:8. Experiments done by Baxter
et al. were based on this value of a [3]. Three dimensional plot of
Fig. 6, dimensionless interstitial pressure distribution, is shown in
Fig. 7. All of these results agree well with experimental data
[3,4,11]. Figure 8 shows the comparison of the current paper with
experimental data (mammary adenocarcinoma s.c.) by Boucher et
al. [15]. In this figure there is good agreement between model and
experiment. Figures 9 and 10 show the IFV and IFP distribution
for a solid tumor embedded in normal tissue as a function of the
dimensionless radius, respectively. As mentioned earlier, boundary
conditions for this case are different from those of an isolated
tumor and are stated in equations (20) and (21).
Figure 11 shows the interstitial pressure distribution in a 1 cm
radius tumor, as a function of a dimensionless radius for different
values of necrotic radii. This figure shows that an increase in the
Figure 15. Interstitial pressure distribution in a 0.25 cm radius tumor, as a function of the dimensionless radius for different
necrotic radii.
doi:10.1371/journal.pone.0020344.g015
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and obviously, when the entire tumor is necrotic, with no
vasculature, the IFP is zero. On the other hand, for a necrotic
radius below a certain size, IFP has its maximum value, which is
the effective pressure, Pe, and this limited size, which can be
considered as a critical necrotic radius or Rnc, can be interpolated
from a graph such as Fig. 12. The same graph for all sizes of solid
tumors studied in this paper is also shown in Fig. 13. From this
figure, for instance, for tumors below a certain size (in this case
0.1 cm), reaching effective pressure, even with a zero value for
their necrotic radius, is not possible. Figures 14, 15 and 16 show
the same parameters as Fig. 11 for the other three tumor sizes,
which follow the same behavior as explained for Fig. 11.
Discussion
The calculated value of IFV for the periphery of an isolated
tumor, shown in Fig. 4, is on the order of 10{7m=s, a finding that
agrees well with experimental data in the literature [3,4,11,40].
These results predict that the fluid filtration is negligible throughout
most part of the tumor and occurs mostly from vessels in the
periphery, well vascularized region. Interstitial fluid pressure
distribution for different values of a and different boundary
conditions, Figs. 5 and 10, shows that IFP is elevated throughout
the tumor and goes down sharply in the periphery of an isolated
tumor or at the normal tissue around an embedded solid tumor.
The immediate result of this high IFP is decreasing blood flow and
therefore insufficient delivery of drug. This general trend for IFP
leads to low filtration of drug from blood vessels in the center of the
tumor and high filtration of drug in the tumor periphery, as shown
inFig. 1.Ontheotherhand,the large pressuregradientresults inan
outwardconvective flowthat washes out the drug extravasated from
blood vessels at the tumor periphery. All of these phenomena are
indicated in Fig. 1, schematically. In both cases, embedded and
isolated tumor, IFP approaches Pe, effective pressure, in the center
of the tumor where the fluid source is minimal, as shown in Figs. 5
and 10. On the other hand, in the periphery, the opposite scenario
occurs; there is minimum pressure and maximum fluid source.
Based on the results of this study, drug delivery can be enhanced by
decreasing IFP in the center of the tumor. This may not be easy to
do but there are some physical and enzymatic methods which can
be applied. For instance, blocking the integrin links between
interstitial matrix and cells decreases IFP and enhances tissue fluid
content. Also, irradiation by remodeling extracellular matrix
decreases IFP in solid tumors [43]. Comparing IFP distribution in
tumors with different radii shows that IFP increases with tumor size.
This study introduces two new parameters, the critical tumor radius
and critical necrotic radius. For tumors below the critical tumor
radius, the maximum interstitial fluid pressure is less than effective
pressure, no matter what the value of the necrotic radius is. In fact,
the transport of the drug to the center of smaller tumors is much
easier than transport to the center of a tumorwhose radiusis greater
than the critical tumor radius, as the maximum IFP is much lower
than effective pressure, Pe. This study also shows that there is a
critical necrotic radius, below which the interstitial fluid pressure at
the center of the tumor is at its maximum value. If the tumor radius
is greater than the critical tumor radius, this maximum pressure is
equal to the effective pressure.
Figure 16. Interstitial pressure distribution in a 0.1 cm radius tumor, as a function of the dimensionless radius for different necrotic
radii.
doi:10.1371/journal.pone.0020344.g016
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Numerical solutions for the simplest case of a homogeneous and
alymphatic tumor demonstrate that, in a uniformly perfused
tumor, high interstitial pressure is the main cause of heterogeneous
drug distribution. The main assumption used to reach this
conclusion is that drug particles flow with the interstitial fluid.
The distribution of interstitial fluid pressure and velocity have
been calculated by numerical solutions to the governing equations.
Comparison of these numerical solutions and experimental data in
the literature shows that the maximum value for the interstitial
pressure occurs at the center of the tumor and decreases towards
the periphery and that the numerical values of interstitial fluid
velocity and the experimental results reported in the literature
agree. Interstitial fluid pressure is not uniform whether the tumor
vasculature is homogeneous or heterogeneous. Thus, in addition
to the heterogeneous distribution of blood supply, high interstitial
pressure plays a significant role in drug distribution in a solid
tumor.
This study also shows that an increase in the necrotic radius
decreases the maximum pressure inside the tumor; the tumor that
is completely necrotic has no vasculature, and thus its interstitial
fluid pressure is zero. This study introduces two new parameters,
the critical tumor radius and critical necrotic radius. Simulation
results show that for tumors below the critical tumor radius, the
maximum interstitial fluid pressure is less than effective pressure (a
parameter determined by vascular pressure, plasma osmotic
pressure, and interstitial osmotic pressure); therefore, the transport
of the drug to the center of smaller tumors is much easier than
transport to the center of a tumor whose radius is greater than the
critical tumor radius, as the maximum interstitial fluid pressure is
much lower than effective pressure. This study shows that there is
a critical necrotic radius, below which the interstitial fluid pressure
at the center of the tumor is at its maximum value. If the tumor
radius is greater than the critical tumor radius, this maximum
pressure is equal to the effective pressure. At above this critical
necrotic radius, the interstitial fluid pressure at the center of the
tumor is below effective pressure.
The numerical model investigated here can be further extended
to apply to anisotropic tissues in terms of properties and geometry.
Capillary distribution in real tissues is heterogeneous and non-
uniform, this numerical model can handle this issue as well.
Microcirculation studies show that for some drugs the relative size
of nanoparticles is comparable to the capillary diameter; therefore,
flow field has to be modeled as a two phase flow. Numerical
method introduced in this paper has the capability of doing such a
two phase flow model.
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